NCT04639778

Brief Summary

Current guideline recommend yearly multidisciplinary postoperative follow-up after bariatric surgery. However, practices remain very heterogeneous, and only a fraction of patients are still follow-up beyond two years after the operation. This study will assess a new care pathway in which the patients are follow-up according to the weight evolution measured by the patient using a connected scale.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
390

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Mar 2021Dec 2026

First Submitted

Initial submission to the registry

May 28, 2020

Completed
6 months until next milestone

First Posted

Study publicly available on registry

November 20, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

March 25, 2021

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

December 24, 2025

Status Verified

December 1, 2025

Enrollment Period

5.7 years

First QC Date

May 28, 2020

Last Update Submit

December 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluate the efficacy of new care pathway

    The main evaluation criterion is the success rate in terms of weight loss defined by an excess weight loss greater than 50%, in the absence undernutrition. Undernutrition is defined by a BMI \< 21 kg / m2 and / or an albumin level \<35 g /l

    3 years

Secondary Outcomes (12)

  • Cost-effectiveness of new care pathway

    3 years

  • Number of visits made by the multidisciplinary team

    3 years

  • Number of postoperative surgical and / or medical complications

    3 years

  • Change of nutritional parameters in the blood of vitamines

    3 years

  • Change of nutritional parameters in the blood of minerals

    3 years

  • +7 more secondary outcomes

Study Arms (2)

Control Group

ACTIVE COMPARATOR

In the control group, patients will follow a care pathway respecting the current recommendations : a systematic clinical visit scheduled each year with the multidisciplinary team.

Other: Control Group

Experimental Group

EXPERIMENTAL

In the intervention group, patients will follow a new care pathway with visits triggered by weight evolution

Other: Intervention Group

Interventions

Clinical visits conducted by a multidisciplinary team every year

Also known as: Clinical visits conducted by a multidisciplinary team every year
Control Group

Clinical visits are triggered by weight evolution measured by connected balance

Also known as: Clinical visits triggered by weight evolution
Experimental Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged\> = at 18 years old Patients who have benefited from a Roux-en-Y Gastric By-Pass or Sleeve Gastrectomy bariatric surgery 2 years ago Preoperative Body Mass Index between 35 kg/m2 and 59 kg/m2 Access to the wired network at home. Social insured patient Patient who signed the informed consent

You may not qualify if:

  • Lack of autonomy for the use of remote monitoring equipment or psychological or psychiatric disorders making it difficult to optimally use the remote monitoring equipment
  • Administrative reasons: inability to receive informed consent information, inability to participate in the entire study, lack of social security coverage, refusal to sign consent, patient under guardianship or justice system.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ch Boulogne-Sur-Mer - Boulogne Sur Mer

Boulogne-sur-Mer, 62321, France

RECRUITING

Hop Claude Huriez Chu Lille

Lille, 59037, France

RECRUITING

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • François Pattou, MD,PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Central Study Contacts

François Pattou, MD,PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Multi-centre, randomised, open, controlled study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2020

First Posted

November 20, 2020

Study Start

March 25, 2021

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

December 24, 2025

Record last verified: 2025-12

Locations